Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigra Llu Zinatnes CentrsfiledCriticalSigra Llu Zinatnes Centrs
Priority to LVP-00-47ApriorityCriticalpatent/LV12736B/en
Publication of LV12736ApublicationCriticalpatent/LV12736A/en
Publication of LV12736BpublicationCriticalpatent/LV12736B/en
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Medicines Containing Material From Animals Or Micro-Organisms
(AREA)
Abstract
The present invention belongs to veterinary medicine, especially to bacteriology and immunology. It may be used for producing antigen against infectious swine diseases caused by Erysipelothrix Rhusiopathiae. The mentioned antigen made by cultivation of Erysipelothrix Rhusiopathiae in Hottinger's medium could be used for immunization of donors (horses, young stock or swine) selected for producing hyper-immune serum against swine erysipelas disease. Animal immunization using concentrated antigen against swine erysipelas disease produced according to mentioned invention guarantees obtaining serum characterised by higher antibody titre. That serum causes no acute anaphylaxis and reduces required number of active immunization.
LVP-00-47A2000-04-182000-04-18Method for producing concentrated antigen composition against swine erysipelas disease
LV12736B
(en)
A vaccine, antibody or antiserum composition, methods of producing an antibody or antiserum and immunizing an animal against a blood-eating ectoparasite, tick cement protein, and use of a protein tick cement